戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 compared the safety and efficacy of placebo, terazosin (10 mg daily), finasteride (5 mg daily), and t
2 e, and alpha(1) receptor antagonists such as terazosin (1b) are used to treat both hypertension and b
3 ), ARC-239 (540 nM), prazosin (4900 nM), and terazosin (5000 nM) correlated best with affinities prev
4 brogate the apoptotic effect of doxazosin or terazosin against human prostate cancer or smooth muscle
5 that the apoptotic activity of doxazosin and terazosin against prostate cells is independent of their
6 pha1-adrenoceptor antagonists (doxazosin and terazosin) against prostate cancer cells is independent
7 n and finasteride was no more effective than terazosin alone.
8 over sites following local administration of terazosin (alpha(1)-antagonist), yohimbine (alpha(2)-ant
9 order with propranolol (beta-AR antagonist), terazosin (alpha1-AR antagonist), or vehicle for an addi
10 ctively (P<0.001 for the comparisons of both terazosin and combination therapy with finasteride and w
11 ctively (P<0.001 for the comparisons of both terazosin and combination therapy with finasteride and w
12  finasteride was not, and the combination of terazosin and finasteride was no more effective than ter
13  symptom scores in the placebo, finasteride, terazosin, and combination-therapy groups at one year we
14  alpha1-adrenoceptor antagonists, doxazosin, terazosin, and tamsulosin, against prostate cancer cell
15 induction, we examined whether doxazosin and terazosin (both piperazinyl quinazolines) affect prostat
16 ibited not only by the alpha(1)AR antagonist Terazosin but also by the CXCR2-specific allosteric inve
17 ngs demonstrate the ability of doxazosin and terazosin (but not tamsulosin) to suppress prostate canc
18                                   Alfuzosin, terazosin, doxazosin and silodosin have all been shown t
19 ation for treatment of symptomatic LUTS/BPH: terazosin, doxazosin, tamsulosin, alfuzosin and silodosi
20 forcement and reduced pellet intake, whereas terazosin enhanced motivation for pellets and reversed p
21                        Neither doxazosin nor terazosin exerted a significant effect on the rate of ce
22 pha1-adrenoceptor antagonists, doxazosin and terazosin, exhibit a potent apoptotic effect against pro
23 renoceptor antagonists such as doxazosin and terazosin have been previously shown to induce apoptosis
24 ted in vivo and found to be more potent than terazosin in both a rat model of prostate tone and a dog
25 rtially rescued with the alpha1AR antagonist terazosin, indicating that alpha1AR signaling participat
26 lpha1-adrenoceptor antagonists doxazosin and terazosin induced apoptosis in prostate epithelial and s
27 f the selective alpha1 adrenergic antagonist terazosin into the basal forebrain.
28 usion of selective antagonists of alpha(1)- (terazosin) or alpha(2)- (atipamezole) receptors or of ei
29 t of prostate cancer cells with doxazosin or terazosin results in a significant loss of cell viabilit
30 dicated that 6FNE markedly depressed whereas terazosin strongly enhanced the apparent functional acti
31    In men with benign prostatic hyperplasia, terazosin was effective therapy, whereas finasteride was
32 changes in fos expression following 6FNE and terazosin were significantly greater than those followin
33 tive alpha1 antagonists such as prazosin and terazosin, with fewer side effects.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。